Patients with sickle cell anemia (SCD) and pulmonary hypertension (PH) have a significantly increased risk of sudden death compared to patients with SCD alone. Sickled red blood cells (RBCs) are stiffer, more dense, more frequently undergo hemolysis, and have a 6-fold shorter lifespan compared to normal red blood cells. Here, we sought to investigate the impact of increased RBC stiffness, independent of other SCD-related biological and mechanical RBC abnormalities, on the hemodynamic changes that ultimately cause PH and increase mortality in SCD. To do so, pulmonary vascular impedance (PVZ) measures were recorded in control C57BL6 mice before and after ~50 μL of blood (Hct=45%) was extracted and replaced with an equal volume of blood containing either untreated RBCs or RBCs chemically-stiffened with glutaraldehyde (Hct=45%). Chemically-stiffened RBCs increased mean pulmonary artery pressure (13.5±0.6 mmHg at baseline to 23.2±0.7 mmHg after the third injection), pulmonary vascular resistance (1.23±0.11 mmHg*min/ml at baseline to 2.24±0.14 mmHg*min/ml after the third injection), and wave reflections (0.31±0.02 at baseline to 0.43±0.03 after the third injection). Chemically-stiffened RBCs also decreased cardiac output, but did not change hematocrit, blood viscosity, pulmonary arterial compliance or heart rate. The main finding of this study is that increased RBC stiffness alone affects pulmonary pulsatile hemodynamics, which suggests that RBC stiffness plays an important role in the development of PH in patients with SCD.
Introduction
Sickle cell anemia or sickle cell disease (SCD) is one of the most common heritable monogenetic diseases in the world. The World Health Organization estimates there are ~275,000 births per year world-wide with SCD [1] . SCD is characterized by a single amino acid substitution of hydrophobic valine for hydrophilic glutamic acid in the β-chain of hemoglobin. This substitution modifies the quaternary structure of the protein, predisposing it to polymerization of hemoglobin in the deoxygenated state which deforms the red blood cell (RBC) into the characteristic sickled shape [2, 3] . Sickled RBCs are biologically and mechanically quite different from normal RBCs, and these differences lead to clinically important consequences. For example, clinically, SCD is associated with ischemia, thrombotic events, oxidative stress and reperfusion injury in multiple organs [4] . Biologically, sickled RBCs have significantly shortened lifespan and more frequently undergo intravascular hemolysis, which releases free hemoglobin into the plasma, which in turn scavenges nitric oxide [5] . The scavenging of nitric oxide can acutely impair vasodilation and chronically cause endothelial cell dysfunction, vascular cell proliferation, and inflammatory stress [4] . Mechanically, sickled RBCs have increased stiffness [6] , which leads to trapping in the microcirculation and downstream ischemia. All of these consequences of SCD can and often do have significant effects on the vasculature including increasing pulmonary vascular resistance (PVR) [4] and systemic arterial wave reflections [7] .
The World Health Organization has found that of the chronic cardiopulmonary effects of SCD, pulmonary hypertension (PH) is the major cause of morbidity and mortality [4] . In fact, patients with SCD-related PH have a substantially increased risk of sudden death compared to those with SCD alone, as high as a 50% within 2 years [8, 9] . SCD is associated with a high prevalence of PH--about 30% [10, 11] . Higher still is the percentage of SCD patients with evidence of PH via lung histology at the time of death--75% [12] . While mortality in patients with SCD-related PH is high, right heart catheterization studies have shown only moderate increases in mean pulmonary artery pressure (mPAP) (30-40 mmHg with SCD compared to 15-20 mmHg in healthy adults [13] ) and pulmonary vascular resistance (PVR) (2.24 Wood units with SCD compared to 1 Wood unit in healthy adults [13] ). Additionally, patients with SCD-related PH have shown little to no improvement with therapies for PH alone [14] [15] [16] .
Therefore, mild PH in patients with SCD, which does not respond to traditional therapies, dramatically increases mortality via mechanisms that are not well understood. The mechanical changes in RBCs with SCD are a likely contributor to abnormal pulmonary vascular hemodynamics. Mechanical changes in RBCs are particularly significant in the low oxygen pulmonary arterial vasculature as RBCs are most likely to sickle in this decreased oxygen environment. How mechanical changes to RBCs in SCD, such as increased stiffness, which has been shown to affect myocardial infarction, essential hypertension, and modify whole blood viscosity [17, 18] , affect right ventricular (RV) afterload has yet to be investigated.
In this study, we sought to investigate the impact of increased RBC stiffness, independent of other SCD-related biological and mechanical RBC abnormalities, on the hemodynamic changes that ultimately cause PH and increase mortality in SCD. We hypothesized that SCD-like RBC rigidity would increase mPAP, PVR and wave reflections in the pulmonary circulation of otherwise healthy lungs. To test this hypothesis, we replaced normal RBCs with chemicallystiffened RBCs in mice and measured pulmonary vascular impedance (PVZ) in vivo. PVZ is the most comprehensive measure of RV afterload since it measures opposition to both steady and oscillatory flow in the pulmonary vasculature. Our results confirmed that RBC stiffness dramatically increases mPAP, PVR and wave reflections, and likely contributes to poor outcomes in SCD-related PH.
Materials and Methods

Mice
Male C57BL6/J mice, 12-14 weeks-old, were obtained from Jackson Laboratory (Bar Harbor, ME) and used either as donors for RBCs or for in vivo experiments. Mice used for in vivo experiments were divided into two separate groups: one injected with control, untreated RBCs 
Red blood cell preparation
Whole blood was drawn from donor mice and centrifuged at 500g for 15 minutes. Then, the plasma, buffy coat and top layer of cells were removed. RBCs were resuspended to a Hct of ~45% with osmolality and PH balanced saline and centrifuged three more times to remove all non-RBC components. To create SCD-like rigidity, RBCs were treated with 0.016% glutaraldehyde for 30 minutes, which has been shown to stiffen RBCs without altering cell shape [19] . Chemically-stiffened RBCs were centrifuged at 500g for 15 minutes 8 times with isotonic saline and then were resuspended to 45% Hct with isotonic buffered saline.
In vivo Hemodynamic Measurements
Mice were instrumented for PVZ measurements as previously described [20, 21] . In brief, mice were anesthetized with urethane (2mg/g body weight), intubated and placed on a ventilator using a tidal volume of ~225 μL and respiratory rate of ~200 breaths/min of room air. A 1.2F cathetertip pressure transducer (Scisense, Inc., London, Ontario, Canada) was inserted into the right carotid artery to monitor systemic arterial pressures and a 1.0F pressure-tip catheter (Millar Instruments, Houston, TX) was inserted into main pulmonary artery through the right ventricle to measure pulmonary arterial pressures. Pressure tracings were recorded at 5 kHz on a custom hemodynamic workstation (Cardiovascular Engineering, Norwood, MA). Measurement of blood flow velocity and main PA inner diameter were performed via ultrasound (Visualsonics, Toronto, Ontario, Canada) with a 40 MHz probe during the surgery and recorded with our custom system as done previously; volumetric flow rate (Q) was calculated using velocity time integral and main PA inner diameter measurements obtained via long axis view [20, 21] .
After all measurements were completed at baseline, ~50 μL of blood was extracted and replaced with an equal volume of saline containing chemically-stiffened RBCs or control RBCs at 45% by volume (Hct=45%). After a five-minute stabilization period, all hemodynamic measurements were repeated, and this cycle was repeated 2 more times, for 3 total blood replacements and 4 total PVZ measurements. Hematocrit was measured with each 50-µL blood collection. Before euthanasia, a 500-μL sample of blood was taken for viscosity analysis. Each sample was drawn into a closed tube for oscillatory tube viscometry (Vilastic-3 Viscoelasticity Analyzer). Samples were sheared with a constant 2 Hz frequency and continually increasing shear rate. The viscometer was calibrated before testing the first sample of the day; at most four samples were tested per day and the duration of testing each sample was 25 minutes. Measurements were performed within 12 hours of collection.
In vivo experiments with chemically-stiffened RBCs and control RBCs were performed by different small animal surgeons trained by one of the authors (TAH).
In vivo Hemodynamic Calculations
Data obtained during our experiments was analyzed as previously described [20, 21] using our custom software and hemodynamic workstation (Cardiovascular Engineering, Norwood, MA). In brief, our software used ECG as a fixed standard of reference for the Q and P waveforms, which then processed and analyzed our data accordingly. All equations used henceforth can be found in these previous publications [20, 21] , including but not limited to pulmonary vascular resistance Z 0 , characteristic impedance Z C , pulmonary arterial compliance Ca, wave reflections RQ, and pulse wave velocity PWV.
Statistical Analysis
For each group, the significances of the overall changes in parameters with blood replacement were assessed using a one-way analysis of variance (ANOVA) for condition (chemicallystiffened or control RBCs) or generalized least squares for repeated measurements (with subsequent blood replacements). Due to the different surgical personnel and consequently different baseline pressure and flow values, comparisons were not performed between control and chemically-stiffened RBC groups. Also, data are presented in figures normalized to the mean baseline (pre-blood replacements) value for each condition; non-normalized data are presented in Table 1 . When the ANOVA reached statistical significance, Tukey multiple comparisons were used for post hoc analysis. Data were considered significant for P-values less than 0.05. All data are presented in terms of means ± standard error. Statistical analysis was performed using R software (Foundation for Statistical Computing, USA, version 2.14.0).
Results
Morphometric effects of blood replacement
The average body weight for the mice in each experimental group was not different (Table 1 and 2). Hematocrit did not change significantly with blood replacement using either chemicallystiffened RBCs or control RBCs (Table 1 and 2).
Hemodynamic effects of blood replacement with chemically-treated RBCs. Mean pulmonary arterial pressure (mPAP) increased significantly after the first and second blood replacements with chemically-stiffened RBCs and remained elevated after the third blood replacement; mPAP did not increase with blood replacement using control (untreated) RBCs (Figure 1 ; Table 1 and 2). Systolic pulmonary arterial pressure (sPAP) and diastolic pulmonary arterial pressure (dPAP) changed in the same ways as mPAP (Table 1 and 2) .
Cardiac output (CO) decreased continuously after the first two blood replacements of chemically-stiffened RBCs and reached a plateau after the third; CO did not decrease with blood replacement using control RBCs (Figure 2 ; Table 1 and 2). Due to increases in mPAP and decreases in CO, total pulmonary vascular resistance (Z 0 ) increased after the first two blood replacements and reached a plateau after the third blood replacement using chemically-stiffened
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RBCs, Z 0 did not change with blood replacement using control RBCs (Figure 3 ; Table 1 and 2).
The same pattern was evident in wave reflections (RQ) (Figure 4 ; Table 1 and 2).
Characteristic impedance (Z C ) tended to decrease with one blood replacement using chemicallystiffened RBCs and significantly decreased after the second blood replacement; Z C did not decrease with blood replacement using control RBCs (Figure 5 ; Table 1 and 2).
The duration of systole decreased with all three blood replacements using chemically-stiffened RBCs; no decrease occurred with blood replacement using control RBCs (Table 1 and 2).
Pulse wave velocity (PWV), pulmonary arterial compliance, systemic systolic pressure, main pulmonary artery diameter and pulse pressure did not change after any blood replacement using either chemically-stiffened RBCs or control RBCs (Table 1 and 2). Heart rate did not change after any infusion of chemically stiffened RBCs and did not decrease after the 1 st or 3 rd infusion of control RBCs, however it did significantly decrease after the 2 nd infusion of control RBCs (Table 1 and 2 ).
Blood viscosity was not changed after three blood replacements with chemically-stiffened RBCs compared to whole blood from donors ( Figure 6 ).
Discussion
The major, novel contribution of this study is demonstrating that RBC stiffening plays a key role in altering pulmonary vascular hemodynamics and increasing RV afterload, including increasing mPAP, PVR and wave reflections.
SCD is known to cause increased RBC stiffness [22, 23] through mechanisms that remain poorly understood but likely involve abnormal RBC membrane properties, abnormal intracellular hemoglobin polymerization, and increased intracellular density. While the impact of each of these RBC abnormalities on blood flow has been tested in vitro [24] [25] [26] [27] [28] , no studies to date have investigated their physiological impact. Here we investigated how RBC stiffening acutely affects pulmonary pulsatile hemodynamics for the first time in vivo. Furthermore, while SCD often affects both RBC mechanics and morphology [29] , there is a separate class of RBCs in sickle cell anemia with altered mechanics but apparently normal morphology [30] . Hence, our results obtained with glutaraldehyde-treated RBCs that have increased stiffness and unchanged morphology [19] are especially relevant to the clinical impact of these SCD RBCs in sickle cell anemia.
To isolate how changes in RBC stiffness affect the pulmonary vasculature, we replaced 50 µL of whole blood with 50 µL of a solution containing chemically-stiffened RBCs (45% by volume, or 45% Hct) three separate times. We demonstrate for the first time that stiffened RBCs increase the static component of RV afterload, PVR, continuously, evidenced by both continual increases in mPAP and continual decreases in cardiac output.
We also demonstrate for the first time that stiffened RBCs alter the pulsatile component of RV afterload. Stiffened RBCs acutely increased wave reflections, which is suggestive of increased arterial stiffening. The increase in mPAP could be a possible explanation for acutely increased pulmonary arterial stiffness due to strain-induced arterial stiffening [31] . Additionally, increased backward wave reflection traveling to the heart (RQ; Figure 4 ) could be caused by trapping of the stiffened RBCs in the lung capillaries. We also found that stiffened RBCs altered the pressure waveform such that the duration of systole was shorter, which may have been caused by increased wave reflections. This finding also suggests that the right ventricle was not able to fully compensate for the effects of chemically stiffened RBCs. However, we did not measure RV function in this study.
We observed a statistically significant decrease in Z C , which would suggest decreased, not increased, pulmonary arterial stiffening. However, as discussed in [20] , Z C depends not only on proximal artery stiffness (with an inverse square root relationship) but also on blood inertance in the proximal arteries (with a square root relationship). The decrease in CO found here decreases inertance, which likely explains the decrease in Z C . Viscous losses along the artery walls and Womersley's number can also affect the longitudinal impedance Z L [32, 33] , which contributes to the characteristic impedance, but neither viscosity nor heart rate (or MPA ID) changed with stiffened RBCs. We did not observe significant differences in pulse wave velocity or pulmonary arterial compliance with stiffened RBCs, but both tended to decrease following the same pattern as Z C . stiffened RBCs. A benefit of the constancy of both hematocrit and whole blood viscosity with our blood replacements is that it does not confound the interpretation of results. That is, the significant increases in mPAP, PVR and wave reflections found here must be due to increased RBC stiffness, as opposed to how changes in RBC stiffness alter viscosity and thereby alter pulmonary pulsatile hemodynamics.
There are four main limitations of this work. First, we did not measure the stiffness of our Tables  Table 1. Body weight, hematocrit and hemodynamic measurements from pulmonary vascular impedance in mice that underwent blood replacement with chemically-stiffened RBCs.
Values are means ± SE; n=11 baseline, 1 st , 2 nd and 3 rd blood replacements. PA, pulmonary arterial, HCT, hematocrit, sAP, systolic aortic pressure, mPAP, mean PA pressure, sPAP, systolic PA pressure, dPAP, diastolic PA pressure, PVR, pulmonary vascular resistance, RQ, PA wave reflections, Ca, PA compliance, CO, cardiac output, Z C , characteristic impedance, Tes, duration of systole, PWV, pulse wave velocity, HR, heart rate, PP, pulse pressure. *P < 0.05 vs. CTL; †P < 0.05 vs. 1 st blood replacement. Values are means ± SE; n=6 baseline, 1 st , 2 nd and 3 rd blood replacements. PA, pulmonary arterial, HCT, hematocrit, sAP, systolic aortic pressure, mPAP, mean PA pressure, sPAP, systolic PA pressure, dPAP, diastolic PA pressure, PVR, pulmonary vascular resistance, RQ, PA wave reflections, Ca, PA compliance, CO, cardiac output, Z C , characteristic impedance, Tes, duration of systole, PWV, pulse wave velocity, HR, heart rate, PP, pulse pressure. *P < 0.05 vs. CTL; †P < 0.05 vs. 1 st blood replacement. 
